Keyword: antibodies

News

Kyowa Kirin to Establish New Biologics Manufacturing Plant in US

13.06.2024 -

Kyowa Kirin announced a new, state-of-the-art manufacturing facility in Sanford, North Carolina, US. Kyowa Kirin will invest up to $530 million (€489 million) in...

News

Shire Takes Novimmune’s Blood Therapy Rights

26.07.2017 - Shire has obtained exclusive worldwide rights from Novimmune for a bi-specific antibody that is currently in pre-clinical development for treating patients with the blood disorders...

News

Glythera Launches ADC Project

12.06.2017 - UK biotech Glythera has launched a project to develop next-generation antibody drug conjugates (ADCs) for difficult-to-treat tumors, backed by funding of £1 million from government...

News

AstraZeneca and Pieris Link on Respiratory Disease

17.05.2017 - AstraZeneca is to collaborate with US-based Pieris Pharmaceuticals to develop novel inhaled drugs for respiratory diseases. The deal will leverage Pieris’ Anticalin platform and...

News

Tusk in UK Cancer Collaboration

16.02.2017 - The UK’s Tusk Therapeutics is joining Cancer Research Technology (CRT) and University College London (UCL) to research, develop and commercialize an antibody-based therapeutic...

News

DSM to Fold Pharma Arm into Venture with Private Equity Firm

20.11.2013 - Dutch food and chemicals group DSM will spin off its pharmaceuticals unit into a new joint venture majority-owned by private equity firm JLL Partners as the company shifts its...

News

DSM, Recepta Announce Contract Manufacturing Agreement

18.07.2012 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced that it has signed a biologics contract manufacturing agreement with its first...

News

DSM Biologics to Acquire Rhobust Technology from Upfront Chromatography

05.05.2010 - DSM Biologics, a business unit of DSM Pharmaceutical products, said it has reached an agreement for the acquisition of the assets and associated business of the Rhobust technology...